It gross profit margin rose from 50.9% to 52.1%. Overseas sales accounted for 65% of the total.
Since it floated at 134p a share in November 2014 Fever-Tree shares have soared to today’s 571p (down 11p on profit taking) - a gain of 326%.
That easily makes it the best London share offering of the last two years.
Rolls believes that such growth can continue. He said: “We currently have more than half the world market of £300 million to £400 million for premium mixers. But analysts reckon that market could grow to £1.6 billion over the next few years. In the short-term premium gin is expected to account for a third of the UK gin market in 2017.”
Fever-Tree is paying its first full year dividend of 3.08p a share which is four times covered by earnings. It ended the year with net cash of £11.6 million up from £3.3 million.
